4.4 Article

Salinomycin - A New Cancer Drug Candidate

Journal

CHEMICAL BIOLOGY & DRUG DESIGN
Volume 79, Issue 3, Pages 235-238

Publisher

WILEY
DOI: 10.1111/j.1747-0285.2011.01287.x

Keywords

drug design; drug discovery; natural product; therapeutic target

Ask authors/readers for more resources

Very recently, it has been shown that it is possible to selectively kill breast cancer stem cells using the ionophore antibiotic, salinomycin. Its ability to kill cancer stem cells and apoptosis-resistant cancer cells may define salinomycin as a novel anticancer drug.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available